US Broker Ratings

Atrium Therapeutics, Inc. (RNA): Investor Outlook Reveals 197.62% Potential Upside

For investors delving into the biotechnology sector, Atrium Therapeutics, Inc. (NASDAQ: RNA) presents a compelling case. Currently priced at $8.40, the company’s substantial market potential is..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unveiling a 74.77% Potential Upside Amidst Biotech Innovations

As investors navigate the ever-evolving landscape of the biotechnology sector, Cytokinetics, Incorporated (NASDAQ: CYTK) emerges as a compelling player with a substantial growth narrative. Headquartered in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Harnessing Biotechnology Innovation with an 18% Upside Potential

For investors keen on the burgeoning biotechnology sector, Krystal Biotech, Inc. (NASDAQ: KRYS) presents a compelling opportunity. With its strategic focus on genetic medicines targeting diseases..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 12% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a storied name in the healthcare sector, continues to attract attention from investors keen on the medical instruments & supplies..

TransMedics Group, Inc. (TMDX) Investor Outlook: Promising Growth with a 28% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) is at the forefront of revolutionizing organ transplant therapy, a vital sector within the healthcare industry. As a commercial-stage medical technology..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Volatility with Strategic Collaborations and Growth Potential

Tempus AI, Inc. (NYSE: TEM), a prominent player in the healthcare technology sector, is capturing investor attention with its innovative services and strategic partnerships. As a..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 19.69% Potential Upside Amid Strong Analyst Ratings

Guardant Health, Inc. (GH), a leader in precision oncology, stands at a fascinating juncture for investors, boasting a substantial market capitalization of $22.47 billion. As a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 9.71% Potential Upside for Investors

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare sector, continues to capture investor attention with its robust portfolio of generic and specialty medicines...

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 16.33% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. The company’s market cap..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Decoding Its 7.58% Potential Upside and Robust Healthcare Portfolio

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands at the intersection of healthcare innovation and investor interest. With a market capitalization of $6.54 billion, this specialty and generic..

RadNet, Inc. (RDNT) Stock Analysis: Exploring Growth Potential with a 33% Upside

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare diagnostics and research sector, is capturing investor attention with its significant growth trajectory and substantial upside..

Centene Corporation (CNC) Stock Report: Navigating Growth and Challenges in the Healthcare Sector

Centene Corporation (NYSE: CNC), a key player in the healthcare plans industry, has been capturing attention with its broad portfolio of services aimed at under-insured families..

Henry Schein, Inc. (HSIC) Investor Outlook: A 15.78% Upside Potential with Strong Analyst Support

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is renowned for its comprehensive portfolio of healthcare products and services targeting dental and medical..

ADMA Biologics Inc (ADMA) Stock Analysis: Uncovering a 64% Upside Potential in Innovative Biotech

ADMA Biologics Inc (NASDAQ: ADMA) is emerging as a compelling opportunity within the biotech sector, offering a substantial upside potential of 64.09% based on current analyst..

BridgeBio Pharma (BBIO) Investor Outlook: A Robust 66.87% Potential Upside Awaits

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a biopharmaceutical leader headquartered in Palo Alto, California, is making significant strides in the healthcare sector with exciting developments in the..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating Growth with a 9.92% Upside Potential

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable entity in the healthcare sector, particularly within the Medical Care Facilities industry. Based in King of..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Leader with 16% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT) has garnered significant attention from investors, particularly in the healthcare sector, where it stands as a formidable player in biotechnology. With..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Potential Amidst Sector Challenges

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the Healthcare sector, specifically in Diagnostics & Research, commands a market capitalization of $14.41 billion...

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 25.91% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a compelling player in the biotechnology sector, boasting a market capitalization of $8.48 billion. This Morrisville, North Carolina-based..

Zimmer Biomet Holdings, Inc. (ZBH): Investor Outlook with a 20% Upside Potential

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a significant player in the healthcare sector, specializing in medical devices. With its innovative suite of orthopedic reconstructive..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds